SBWire

MarketHATCH Patient Acquisition Programs benefit patients, providers,pharmacists and manufacturers. Our coupon and rebate programs are cost effective, easily implemented and impacted. We always have our focus on agreat patient experience.

Albert Einstein College of Medicine of Yeshiva University-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information, deals and alliances and recent news on the company including key milestones.

Albert David Limited-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.

Akrimax Pharmaceuticals, LLC-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.

Ahn-Gook Pharmaceutical Co., Ltd.-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.

Ahn-Gook Pharmaceutical Co., Ltd.-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.

AFFiRiS GmbH-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.

ReportsandReports announce it will carry Benchmarking the Pharmaceutical Market by Drug Delivery to 2014 Market Research Report in its Store.

ReportsandReports announce it will carry Brazil Pharmaceutical Market Overview – Expanding healthcare access drives double-digit sales growth Market Research Report in its Store.

Turkey, a ‘pharmerging’ market, has evolved to this status after a series of economic and healthcare reforms. The country was at the verge of financial collapse until 2001 with inflation running in near three digits. However, the economic reforms implemented by the country have turned it into a dynamic economy. The country’s pharmaceutical industry has been a frontrunner in these reforms. Turkey has a growing pharmaceutical sector with around 300 pharmaceutical companies selling up to 1.3bn units of products every year. Factors that have fuelled the growth of the pharmaceutical industry in the country include economic growth, high healthcare expenditures, a young workforce and a host of companies delivering drugs to the populace.

Japan, the second single largest drug market in the world (historically known to be a land of innovation) is a leading nation in terms of scientific research, technology, machinery and medical research. Japan has been an industrially active nation ever since it adopted Western technology and gained industrial supremacy in the early years of the 20th century. In 2008, the services sector (72.1%) contributed the major portion of GDP growth in Japan followed by industries (26.4%) and agriculture (1.5%).

The pharmaceutical and biopharmaceutical industries are engaged in a business environment which is witnessing a dramatic escalation of R&D costs, key patent expiries, and sustained high attrition rates for new molecules in development.

Injectable bio-implants provide rapid non-surgical treatments and offer effective replacement, restoration, or modulation of function to lost, damaged, or dysregulated physiology. Market opportunities for injectable bio-implants are high in an increasingly aging population that demands fast, effective, and safe treatments for age-related conditions. Both medical and aesthetic applications for biomaterials make the market opportunities for injectable bio-implants highly attractive for drug and device manufacturers. However, biocompatibility is crucial for any implantable biomaterial to integrate into the host anatomy and prevent an immunogenic response.

Australia is the most attractive market for pharmaceutical investment in the Asia Pacific region which is primarily due to its growing and ageing population, excellent access to medicines, and fast-recovering economy.

Candida symptoms can vary from mild to severe. They can be constant or sporadic. They are always frustrating and difficult to get rid of unless you understand the cause and how to treat it. Before discussing Candida symptoms it is important to understand what Candida is. Candida is a form of yeast that occurs and lives naturally within everyone’s body. Our bodies have a natural ability to control the growth of Candida and prevent the symptoms of Candida overgrowth.

In 2007, due to the impending patent cliff and the consequent need to cut costs, big pharma began for the first time to outsource chemical API manufacturing to China and India. Prior to this only generic drug companies had manufactured in the two countries. Since then, big pharma has been undergoing waves of layoffs that have been accelerated by the economic downturn, with manufacturing and sales being particularly affected, and outsourcing levels in R&D and manufacturing are expected to increase further in the future.

METTLER TOLEDO's Weighing Solutions Team announced the introduction of new GWPExcellence (TM) safety features in the Excellence Plus XP Balance Line.

Mettler Toledo, the leading manufacturer of precision instruments, developed the Risk Check: An online tool to analyze the weighing risk of balances from all kinds of manufacturers.

n situ monitoring of suspension and emulsions in chemical, petrochemical and pharmaceutical research and manufacturing typically involves measuring turbidity.

ResearchInChina announces the availability of a new research report – China Vaccine Industry Report, 2009-2010.

The generic drug market is growing strongly as health plan payers around the world continue to implement incentives for participants, pharmacists, doctors and others to use generic, rather than branded, medications. Facing rising patent expirations, pharmaceutical companies are diversifying into their own generics businesses, creating a vibrant market for generic drug company acquisitions as they seek to capture market share. At the same time, startups and other generic drug companies are attempting to expand, seeking capital through private investments, public offerings and other means; and government-run companies in China, Latin America and other regions are privatizing.

This report carries out a detailed analysis of the provisions of healthcare reform and their effects on the pharmaceutical industry. Strategies for optimizing promotional activities and pipelines for the future are examined.

The Eastern European pharmaceutical companies comprise both Eastern Europe-based and MNCs. This chapter provides an insight into the current state of Eastern European pharmaceutical industry as well as the evolving trends.

The leading players in the Indian pharmaceutical market comprise both India-based and MNCs. This report provides an insight to the current state of Indian pharmaceutical industry as well as the evolving trends. This report analyzes the Indian pharmaceutical industry in light of market size, key drivers and resistors, trends and competitive positioning in the global market.

ResearchInChina announces the availability of a new research report – Global and China Biopharmaceutical Industry Report, 2010.